Authors:
Beaudeux, JL
Therond, P
Bonnefont-Rousselot, D
Gardes-Albert, M
Legrand, A
Delattre, J
Peynet, J
Citation: Jl. Beaudeux et al., Comparison of the effects of O-2(center dot-)/HO center dot free radical and copper ions-oxidized LDL or lipoprotein(a) on the endothelial cell releases of tissue Plasminogen Activator and Plasminogen Activator Inhibitor-1, LIFE SCI, 69(20), 2001, pp. 2371-2382
Authors:
Kevelaitis, E
Oubenaissa, A
Mouas, C
Peynet, J
Menasche, P
Citation: E. Kevelaitis et al., Ischemic preconditioning with opening of mitochondrial adenosine triphosphate-sensitive potassium channels or Na+/H+ exchange inhibition: Which is the best protective strategy for heart transplants?, J THOR SURG, 121(1), 2001, pp. 155-162
Authors:
Kevelaitis, E
Patel, AP
Oubenaissa, A
Peynet, J
Mouas, C
Yellon, DM
Menasche, P
Citation: E. Kevelaitis et al., Backtable heat-enhanced preconditioning: A simple and effective means of improving function of heart transplants, ANN THORAC, 72(1), 2001, pp. 107-112
Authors:
Ganne, F
Vasse, M
Beaudeux, JL
Peynet, J
Francois, A
Mishal, Z
Chartier, A
Tobelem, G
Vannier, JP
Soria, J
Soria, C
Citation: F. Ganne et al., Cerivastatin, an inhibitor of HMG-CoA reductase, inhibits urokinase/urokinase-receptor expression and MMP-9 secretion by peripheral blood monocytes -A possible protective mechanism against atherothrombosis, THROMB HAEM, 84(4), 2000, pp. 680-688
Authors:
Kevelaitis, E
Oubenaissa, A
Mouas, C
Peynet, J
Menasche, P
Citation: E. Kevelaitis et al., Opening of mitochondrial potassium channels - A new target for graft preservation strategies?, TRANSPLANT, 70(4), 2000, pp. 576-578
Authors:
Belhomme, D
Peynet, J
Florens, E
Tibourtine, O
Kitakaze, M
Menasche, P
Citation: D. Belhomme et al., Is adenosine preconditioning truly cardioprotective in coronary artery bypass surgery?, ANN THORAC, 70(2), 2000, pp. 590-594
Authors:
Bonnefont-Rousselot, D
Therond, P
Beaudeux, JL
Peynet, J
Legrand, A
Delattre, J
Citation: D. Bonnefont-rousselot et al., High density lipoproteins (HDL) and the oxidative hypothesis of atherosclerosis, CLIN CH L M, 37(10), 1999, pp. 939-948
Authors:
Collet, JP
Mishal, Z
Lesty, C
Mirshahi, M
Peynet, J
Baumelou, A
Bensman, A
Soria, J
Soria, C
Citation: Jp. Collet et al., Abnormal fibrin clot architecture in nephrotic patients is related to hypofibrinolysis: influence of plasma biochemical modifications - A possible mechanism for the high thrombotic tendency?, THROMB HAEM, 82(5), 1999, pp. 1482-1489
Authors:
Parquet, A
Laurian, Y
Rothschild, C
Navarro, R
Guerois, C
Gay, V
Durin, A
Peynet, J
Sultan, Y
Citation: A. Parquet et al., Incidence of factor IX inhibitor development in severe haemophilia B patients treated with only one brand of high purity plasma derived factor IX concentrate, THROMB HAEM, 82(4), 1999, pp. 1247-1249
Authors:
Ganne, F
Vasse, M
Beaudeux, JL
Peynet, J
Francois, A
Paysant, J
Lenormand, B
Collet, JP
Vannier, JP
Soria, J
Soria, C
Citation: F. Ganne et al., Increased expression of u-PA and u-PAR on monocytes by LDL and Lp(a) lipoproteins - Consequences for plasmin generation and monocyte adhesion, THROMB HAEM, 81(4), 1999, pp. 594-600
Authors:
Kevelaitis, E
Peynet, J
Mouas, C
Launay, JM
Menasche, P
Citation: E. Kevelaitis et al., Opening of potassium channels - The common cardioprotective link between preconditioning and natural hibernation?, CIRCULATION, 99(23), 1999, pp. 3079-3085
Authors:
Belhomme, D
Peynet, J
Louzy, M
Launay, JM
Kitakaze, M
Menasche, P
Citation: D. Belhomme et al., Evidence for preconditioning by isoflurane in coronary artery bypass graftsurgery, CIRCULATION, 100(19), 1999, pp. 340-344
Authors:
Kevelaitis, E
Oubenaissa, A
Peynet, J
Mouas, C
Menasche, P
Citation: E. Kevelaitis et al., Preconditioning by mitochondrial ATP-sensitive potassium channel openers -An effective approach for improving the preservation of heart transplants, CIRCULATION, 100(19), 1999, pp. 345-350
Authors:
Goudemand, J
Peynet, J
Chambost, H
Negrier, C
Briquel, ME
Claeyssens, S
Derlon-Borel, A
Guerois, C
Caron, C
Scherrmann, JM
Debray, M
Bridey, F
Citation: J. Goudemand et al., A cross-over pharmacokinetic study of a double viral inactivated factor IXconcentrate (15 nm filtration and SD) compared to a SD factor IX concentrate, THROMB HAEM, 80(6), 1998, pp. 919-924